On the eve of the second trial over its painkiller Vioxx, drug giant Merck & Co on Friday sought to reassure investors that it has the money and determination to fight the mounting lawsuits and liability over the withdrawn drug.
"We are in this for the long haul. We have both the resources and the resolve to address these cases one by one over many years," Kenneth Frazier, Merck's general counsel and senior vice president, told reporters during a late-morning conference call.
"Merck's future is both secure and promising," he said.
Analysts have estimated Merck's liability at anywhere from several billion dollars up to US$50 billion.
Frazier seemed to backpedal slightly on statements he and Merck spokespeople made last month indicating the company might settle some lawsuits involving a relatively small number of Vioxx users believed to have had limited heart risk factors and to have taken the drug for 18 months or more.
"We will have to make decisions about what's the right way to proceed with those cases," Frazier said, but he also said several times that Merck will fight each case individually.
Merck pulled Vioxx from the market last September after research linked the popular arthritis drug to increased risk of heart attack and stroke after 18 months use, although some plaintiff attorneys and doctors say the risk began rising after much shorter use.
Frazier said the "very capable legal team" representing Merck in a trial starting Monday in Atlantic City would stick with the company strategy of presenting "sound, reliable evidence" to convince the jury that Vioxx did not cause the plaintiff's heart attack. He said the plaintiff, Frederick Humeston of Boise, Idaho, who survived the heart attack four years ago, had multiple cardiac risk factors and only took Vioxx intermittently.
Frazier said a major financial rating agency, which he did not identify, recently affirmed Merck's financial strength.
He said that will allow the company to continue investing in research on future drugs.
DAMAGE REPORT: Global central banks are assessing war-driven inflation risks as the law of unintended consequences careens around the world, spiking oil prices Central banks from Washington to London and from Jakarta to Taipei are about to make their first assessments of economic damage after more than two weeks of conflict between the US and Iran. Decisions this week encompassing every member of the G7 and eight of the world’s 10 most-traded currency jurisdictions are likely to confirm to investors that the specter of a new inflation shock is already worrying enough to prompt heightened caution. The US Federal Reserve is widely expected to do exactly what everyone anticipated weeks ahead of its March 17-18 policy gathering: hold rates steady. The narrative surrounding that
Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) share of the global foundry market rose to almost 70 percent last year amid booming demand for artificial intelligence (AI), market information advisory firm TrendForce Corp (集邦科技) said on Thursday. The contract chipmaker posted US$122.54 billion in revenue, up 36.1 percent from a year earlier, accounting for 69.9 percent of the global market, TrendForce said. Its share was up from 64.4 percent in 2024, it said. TSMC’s closest rival, Samsung Electronics, was a distant second, posting US$12.63 billion in sales, down 3.9 percent from a year earlier, for a 7.2 percent share of the global market. In the
At a massive shipyard in North Vancouver, Canadian workers grind metal beams for a powerful new icebreaker crucial to cementing the country’s presence in the increasingly contested arctic. Icebreakers are specialized, expensive vessels able to navigate in the frozen far north. And “this is the crown jewel,” said Eddie Schehr, vice president of production at the Seaspan shipyard. For Canadian Prime Minister Mark Carney, who heads to Norway next Friday to observe arctic defense drills involving troops from 14 NATO states, Canada’s extreme north has emerged as a strategic priority. “Canada is and forever will be an Arctic nation,” he said ahead of
Chinese entrepreneur Frank Gao used to spend long hours running his social media accounts but now outsources the chore to artificial intelligence (AI) agent tool OpenClaw, which is taking China by storm despite official warnings over cybersecurity. OpenClaw, created in November by an Austrian coder, differs from bots such as ChatGPT because it can execute real-life tasks such as sending e-mails, organizing files or even booking flight tickets. “Since January, I’ve spent hours on the lobster every day,” Gao said in an interview, referring to OpenClaw’s red crustacean mascot. “We’re family.” After downloading OpenClaw, users connect it to artificial intelligence models of their
RSS